Gelteq Limited
GELS•NASDAQ•Healthcare•Drug Manufacturers - Specialty & Generic

About Gelteq

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyAUD - AUD
TypeStock

Contact Information

Websitewww.gelteq.com
Phone61 3 9087 3990
Address
Monash Innovation Labs, G.60, 22 Alliance Lane Clayton, VIC 3800 Australia

Corporate Identifiers

CIK0001920092
ISINAU0000218109
SIC2834

Leadership Team & Key Executives

Nathan Jacob Givoni
Co-Founder, Chief Executive Officer and Executive Director
Simon Hayden Szewach
Co-Founder and Non-Executive Chairman
Thuy-Linh Gigler
Chief Financial Officer
Dr. Paul M. Wynne Ph.D.
Chief Scientific Officer
Adam Bendell
President of U.S. Operations
Matthew Jones
Head of Sports Performance